Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Journey Medical (DERM) Return on Equity (2021 - 2025)

Historic Return on Equity for Journey Medical (DERM) over the last 5 years, with Q3 2025 value amounting to 0.38%.

  • Journey Medical's Return on Equity rose 12700.0% to 0.38% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.38%, marking a year-over-year increase of 12700.0%. This contributed to the annual value of 0.73% for FY2024, which is 5200.0% down from last year.
  • As of Q3 2025, Journey Medical's Return on Equity stood at 0.38%, which was up 12700.0% from 0.43% recorded in Q2 2025.
  • Journey Medical's 5-year Return on Equity high stood at 0.07% for Q2 2024, and its period low was 10.46% during Q2 2023.
  • For the 5-year period, Journey Medical's Return on Equity averaged around 1.69%, with its median value being 1.09% (2022).
  • Its Return on Equity has fluctuated over the past 5 years, first plummeted by -93800bps in 2023, then skyrocketed by 105300bps in 2024.
  • Over the past 5 years, Journey Medical's Return on Equity (Quarter) stood at 2.9% in 2021, then soared by 53bps to 1.37% in 2022, then surged by 85bps to 0.2% in 2023, then plummeted by -362bps to 0.94% in 2024, then skyrocketed by 60bps to 0.38% in 2025.
  • Its Return on Equity stands at 0.38% for Q3 2025, versus 0.43% for Q2 2025 and 0.4% for Q1 2025.